Meta-Flux

Meta-Flux is a Montreal-based biotechnology company specializing in fluxomics, an advanced branch of metabolomics that measures the dynamic flow of molecules through metabolic pathways. By leveraging its proprietary platform, the company identifies unique metabolic signatures to accelerate drug discovery and develop precision diagnostics. Unlike traditional metabolomics which provides a static snapshot, Meta-Flux's technology measures metabolic rates to provide a functional readout of cellular health and disease progression. The company focuses on high-impact areas including metabolic diseases, oncology, and infectious diseases, offering insights into disease mechanisms and therapeutic responses. Their approach enables the identification of novel biomarkers and the validation of drug targets through functional metabolic readouts.